Regulations.gov document
Nexgen Pharma, Inc. - Balanced B-100 Tabs - Supports Cardiovascular System and Mental…
Other · FDA-2011-S-0932 · posted Jun 20, 2017
Key facts
| Document ID | FDA-2011-S-0932-2511 |
|---|---|
| Title | Nexgen Pharma, Inc. - Balanced B-100 Tabs - Supports Cardiovascular System and Mental Health |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2011-S-0932 |
| Posted | Jun 20, 2017 |
| Comment period opens | Jun 20, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: